Who owns Infinity Pharmaceuticals?

Key details on Infinity Pharmaceuticals (Ticker: INFI)

Who owns Infinity Pharmaceuticals?

Is INFI a good stock to own? Find out who bought Infinity Pharmaceuticals, who sold Infinity Pharmaceuticals (INFI) stock, and who holds a large position in Infinity Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Vanguard 6.23M $48.91M Dec. 31, 2015
GOLDMAN SACHS 5.45M $46.02M Sept. 30, 2015
OrbiMed Advisors 4.42M $37.32M Sept. 30, 2015
Deerfield Management Company 3.91M $33.05M Sept. 30, 2015
STATE STREET CORPORATION 3.73M $31.53M Sept. 30, 2015
S.A.C. Capital Advisors 3.41M $40.56M March 31, 2014
Perceptive Advisors 3.25M $157.49M March 31, 2013
T. Rowe Price Associates 3.17M $55.36M Sept. 30, 2013
Quogue Capital 2.91M $101.68M Dec. 31, 2012
BlackRock Fund Advisors 2.75M $21.56M Dec. 31, 2015
BB Biotech AG 2.70M $21.20M Dec. 31, 2015
FMR 2.35M $18.47M Dec. 31, 2015
Point72 Asset Management 2.20M $29.52M Sept. 30, 2014
BVF 2.18M $19.31M Dec. 31, 2011
Wellington Management Company 2.14M $16.76M Dec. 31, 2015
Gail Mannix 1.45M $11.41M Dec. 31, 2015
Broadfin Capital 1.44M $425.27M June 30, 2014
BlackRock Institutional Trust Company, N.A. 1.38M $10.80M Dec. 31, 2015
QVT Financial 1.33M $23.12M Sept. 30, 2013